Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

An Interpretable Deep Hierarchical Semantic Convolutional Neural Network for Lung Nodule Malignancy Classification.

Shen S, Han SX, Aberle DR, Bui AA, Hsu W.

Expert Syst Appl. 2019 Aug 15;128:84-95. doi: 10.1016/j.eswa.2019.01.048. Epub 2019 Jan 18.

PMID:
31296975
2.

Micronodules Detected on Computed Tomography During the National Lung Screening Trial: Prevalence and Relation to Positive Studies and Lung Cancer.

Munden RF, Chiles C, Boiselle PM, Sicks JD, Aberle DR, Gatsonis CA.

J Thorac Oncol. 2019 Sep;14(9):1538-1546. doi: 10.1016/j.jtho.2019.05.045. Epub 2019 Jul 8.

PMID:
31295576
3.

The Immune Contexture Associates with the Genomic Landscape in Lung Adenomatous Premalignancy.

Krysan K, Tran LM, Grimes BS, Fishbein GA, Seki A, Gardner BK, Walser TC, Salehi-Rad R, Yanagawa J, Lee JM, Sharma S, Aberle DR, Spira AE, Elashoff DA, Wallace WD, Fishbein MC, Dubinett SM.

Cancer Res. 2019 May 29. doi: 10.1158/0008-5472.CAN-19-0153. [Epub ahead of print]

PMID:
31142513
4.

MILD trial, strong confirmation of lung cancer screening efficacy.

Schabath MB, Aberle DR.

Nat Rev Clin Oncol. 2019 Sep;16(9):529-530. doi: 10.1038/s41571-019-0231-3. No abstract available.

PMID:
31118491
5.

External validation and recalibration of the Brock model to predict probability of cancer in pulmonary nodules using NLST data.

Winter A, Aberle DR, Hsu W.

Thorax. 2019 Jun;74(6):551-563. doi: 10.1136/thoraxjnl-2018-212413. Epub 2019 Mar 21.

PMID:
30898897
6.

Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma.

Scafoglio CR, Villegas B, Abdelhady G, Bailey ST, Liu J, Shirali AS, Wallace WD, Magyar CE, Grogan TR, Elashoff D, Walser T, Yanagawa J, Aberle DR, Barrio JR, Dubinett SM, Shackelford DB.

Sci Transl Med. 2018 Nov 14;10(467). pii: eaat5933. doi: 10.1126/scitranslmed.aat5933.

7.

Evaluating Casama: Contextualized semantic maps for summarization of lung cancer studies.

Garcia-Gathright JI, Matiasz NJ, Adame C, Sarma KV, Sauer L, Smedley NF, Spiegel ML, Strunck J, Garon EB, Taira RK, Aberle DR, Bui AAT.

Comput Biol Med. 2018 Jan 1;92:55-63. doi: 10.1016/j.compbiomed.2017.10.034. Epub 2017 Nov 3.

8.

Implementing lung cancer screening: the US experience.

Aberle DR.

Clin Radiol. 2017 May;72(5):401-406. doi: 10.1016/j.crad.2016.12.003. Epub 2017 Jan 6. Review.

PMID:
28069160
9.

Interval lung cancer after a negative CT screening examination: CT findings and outcomes in National Lung Screening Trial participants.

Gierada DS, Pinsky PF, Duan F, Garg K, Hart EM, Kazerooni EA, Nath H, Watts JR Jr, Aberle DR.

Eur Radiol. 2017 Aug;27(8):3249-3256. doi: 10.1007/s00330-016-4705-8. Epub 2017 Jan 3.

PMID:
28050695
10.

Indeterminate Pulmonary Nodules: How to Minimize Harm.

Barjaktarevic I, Arenberg D, Grimes BS, Ruchalski K, Aberle DR.

Semin Respir Crit Care Med. 2016 Oct;37(5):689-707. Epub 2016 Oct 12. Review.

PMID:
27732991
11.

Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial.

Schabath MB, Massion PP, Thompson ZJ, Eschrich SA, Balagurunathan Y, Goldof D, Aberle DR, Gillies RJ.

PLoS One. 2016 Aug 10;11(8):e0159880. doi: 10.1371/journal.pone.0159880. eCollection 2016.

12.

Consumers' Patient Portal Preferences and Health Literacy: A Survey Using Crowdsourcing.

Zide M, Caswell K, Peterson E, Aberle DR, Bui AA, Arnold CW.

JMIR Res Protoc. 2016 Jun 8;5(2):e104. doi: 10.2196/resprot.5122.

13.

Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.

Patz EF Jr, Greco E, Gatsonis C, Pinsky P, Kramer BS, Aberle DR.

Lancet Oncol. 2016 May;17(5):590-9. doi: 10.1016/S1470-2045(15)00621-X. Epub 2016 Mar 18.

14.

Toward patient-tailored summarization of lung cancer literature.

Garcia-Gathright JI, Matiasz NJ, Garon EB, Aberle DR, Taira RK, Bui AAT.

IEEE EMBS Int Conf Biomed Health Inform. 2016 Feb;2016:449-452. doi: 10.1109/BHI.2016.7455931. Epub 2016 Apr 21.

15.

Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.

Weber WA, Gatsonis CA, Mozley PD, Hanna LG, Shields AF, Aberle DR, Govindan R, Torigian DA, Karp JS, Yu JQ, Subramaniam RM, Halvorsen RA, Siegel BA; ACRIN 6678 Research team; MK-0646-008 Research team.

J Nucl Med. 2015 Aug;56(8):1137-43. doi: 10.2967/jnumed.114.147728. Epub 2015 Apr 23.

16.

Representing and extracting lung cancer study metadata: study objective and study design.

Garcia-Gathright JI, Oh A, Abarca PA, Han M, Sago W, Spiegel ML, Wolf B, Garon EB, Bui AA, Aberle DR.

Comput Biol Med. 2015 Mar;58:63-72. doi: 10.1016/j.compbiomed.2015.01.004. Epub 2015 Jan 13.

17.

Imaging-histologic discordance at percutaneous biopsy of the lung.

Oh AS, Arnold CW, Vangala S, Wallace WD, Genshaft SJ, Sarma K, Aberle DR.

Acad Radiol. 2015 Apr;22(4):481-7. doi: 10.1016/j.acra.2014.11.009. Epub 2015 Jan 15.

18.

Cost-effectiveness of CT screening in the National Lung Screening Trial.

Black WC, Gareen IF, Soneji SS, Sicks JD, Keeler EB, Aberle DR, Naeim A, Church TR, Silvestri GA, Gorelick J, Gatsonis C; National Lung Screening Trial Research Team.

N Engl J Med. 2014 Nov 6;371(19):1793-802. doi: 10.1056/NEJMoa1312547.

19.

Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.

Gierada DS, Pinsky P, Nath H, Chiles C, Duan F, Aberle DR.

J Natl Cancer Inst. 2014 Oct 18;106(11). pii: dju284. doi: 10.1093/jnci/dju284. Print 2014 Nov.

20.

Toward clinically usable CAD for lung cancer screening with computed tomography.

Brown MS, Lo P, Goldin JG, Barnoy E, Kim GH, McNitt-Gray MF, Aberle DR.

Eur Radiol. 2014 Nov;24(11):2719-28. doi: 10.1007/s00330-014-3329-0. Epub 2014 Jul 24.

PMID:
25052078
21.

The International Association Study Lung Cancer (IASLC) Strategic Screening Advisory Committee (SSAC) response to the USPSTF recommendations.

Field JK, Aberle DR, Altorki N, Baldwin DR, Dresler C, Duffy SW, Goldstraw P, Hirsch FR, Pedersen JH, de Koning HJ, Mulshine JL, Sullivan DC, Tsao MS, Travis WD; International Association for the Study of Lung Cancer Strategic Screening Advisory Committee.

J Thorac Oncol. 2014 Feb;9(2):141-3. doi: 10.1097/JTO.0000000000000060. No abstract available.

22.

Data model for personalized patient health guidelines: an exploratory study.

McNamara M, Sarma K, Aberle DR, Bui AA, Arnold C.

AMIA Annu Symp Proc. 2014 Nov 14;2014:1835-44. eCollection 2014.

23.

Overdiagnosis in low-dose computed tomography screening for lung cancer.

Patz EF Jr, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemägi MC, Chiles C, Black WC, Aberle DR; NLST Overdiagnosis Manuscript Writing Team.

JAMA Intern Med. 2014 Feb 1;174(2):269-74. doi: 10.1001/jamainternmed.2013.12738. Erratum in: JAMA Intern Med. 2014 May;174(5):828.

24.

Results of the two incidence screenings in the National Lung Screening Trial.

Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gatsonis CA, Gierada DS, Jain A, Jones GC, Mahon I, Marcus PM, Rathmell JM, Sicks J; National Lung Screening Trial Research Team.

N Engl J Med. 2013 Sep 5;369(10):920-31. doi: 10.1056/NEJMoa1208962.

25.

Imaging-based observational databases for clinical problem solving: the role of informatics.

Bui AA, Hsu W, Arnold C, El-Saden S, Aberle DR, Taira RK.

J Am Med Inform Assoc. 2013 Nov-Dec;20(6):1053-8. doi: 10.1136/amiajnl-2012-001340. Epub 2013 Jun 17.

26.

Results of initial low-dose computed tomographic screening for lung cancer.

National Lung Screening Trial Research Team, Church TR, Black WC, Aberle DR, Berg CD, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gierada DS, Jones GC, Mahon I, Marcus PM, Sicks JD, Jain A, Baum S.

N Engl J Med. 2013 May 23;368(21):1980-91. doi: 10.1056/NEJMoa1209120.

27.

Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial.

Aberle DR, Abtin F, Brown K.

J Clin Oncol. 2013 Mar 10;31(8):1002-8. doi: 10.1200/JCO.2012.43.3110. Epub 2013 Feb 11. Review.

28.

Integrating pathology and radiology disciplines: an emerging opportunity?

Sorace J, Aberle DR, Elimam D, Lawvere S, Tawfik O, Wallace WD.

BMC Med. 2012 Sep 5;10:100. doi: 10.1186/1741-7015-10-100.

29.

Expert opinion: barriers to CT screening for lung cancer.

Aberle DR, Henschke CI, McLoud TC, Boiselle PM.

J Thorac Imaging. 2012 Jul;27(4):208. doi: 10.1097/RTI.0b013e318253d74d. No abstract available.

PMID:
22695061
30.

Lung cancer screening: promise and pitfalls.

Berg CD, Aberle DR, Wood DE.

Am Soc Clin Oncol Educ Book. 2012:450-7. doi: 10.14694/EdBook_AM.2012.32.450.

PMID:
24451779
31.

International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report.

Field JK, Smith RA, Aberle DR, Oudkerk M, Baldwin DR, Yankelevitz D, Pedersen JH, Swanson SJ, Travis WD, Wisbuba II, Noguchi M, Mulshine JL; IASLC CT Screening Workshop 2011 Participants.

J Thorac Oncol. 2012 Jan;7(1):10-9. doi: 10.1097/JTO.0b013e31823c58ab.

32.

Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST).

Kramer BS, Berg CD, Aberle DR, Prorok PC.

J Med Screen. 2011;18(3):109-11. doi: 10.1258/jms.2011.011055. No abstract available.

33.

The National Lung Screening Trial's Endpoint Verification Process: determining the cause of death.

Marcus PM, Gareen IF, Miller AB, Rosenbaum J, Keating K, Aberle DR, Berg CD.

Contemp Clin Trials. 2011 Nov;32(6):834-40. doi: 10.1016/j.cct.2011.07.003. Epub 2011 Jul 18. Review.

34.

Lung cancer chemoprevention with celecoxib in former smokers.

Mao JT, Roth MD, Fishbein MC, Aberle DR, Zhang ZF, Rao JY, Tashkin DP, Goodglick L, Holmes EC, Cameron RB, Dubinett SM, Elashoff R, Szabo E, Elashoff D.

Cancer Prev Res (Phila). 2011 Jul;4(7):984-93. doi: 10.1158/1940-6207.CAPR-11-0078.

35.

Reduced lung-cancer mortality with low-dose computed tomographic screening.

National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD.

N Engl J Med. 2011 Aug 4;365(5):395-409. doi: 10.1056/NEJMoa1102873. Epub 2011 Jun 29.

36.

The Lung Image Database Consortium (LIDC) and Image Database Resource Initiative (IDRI): a completed reference database of lung nodules on CT scans.

Armato SG 3rd, McLennan G, Bidaut L, McNitt-Gray MF, Meyer CR, Reeves AP, Zhao B, Aberle DR, Henschke CI, Hoffman EA, Kazerooni EA, MacMahon H, Van Beeke EJ, Yankelevitz D, Biancardi AM, Bland PH, Brown MS, Engelmann RM, Laderach GE, Max D, Pais RC, Qing DP, Roberts RY, Smith AR, Starkey A, Batrah P, Caligiuri P, Farooqi A, Gladish GW, Jude CM, Munden RF, Petkovska I, Quint LE, Schwartz LH, Sundaram B, Dodd LE, Fenimore C, Gur D, Petrick N, Freymann J, Kirby J, Hughes B, Casteele AV, Gupte S, Sallamm M, Heath MD, Kuhn MH, Dharaiya E, Burns R, Fryd DS, Salganicoff M, Anand V, Shreter U, Vastagh S, Croft BY.

Med Phys. 2011 Feb;38(2):915-31.

37.

Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial.

Duda C, Mahon I, Chen MH, Snyder B, Barr R, Chiles C, Falk R, Fishman EK, Gemmel D, Goldin JG, Brown K, Munden RF, Vydareny K, Aberle DR.

Clin Trials. 2011 Apr;8(2):214-23. doi: 10.1177/1740774510396742. Epub 2011 Jan 17.

38.

Baseline characteristics of participants in the randomized national lung screening trial.

National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Clapp JD, Clingan KL, Gareen IF, Lynch DA, Marcus PM, Pinsky PF.

J Natl Cancer Inst. 2010 Dec 1;102(23):1771-9. doi: 10.1093/jnci/djq434. Epub 2010 Nov 22. Erratum in: J Natl Cancer Inst. 2011 Oct 19;103(20):1560.

39.

The National Lung Screening Trial: overview and study design.

National Lung Screening Trial Research Team, Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Gatsonis C, Goldin J, Gohagan JK, Hillman B, Jaffe C, Kramer BS, Lynch D, Marcus PM, Schnall M, Sullivan DC, Sullivan D, Zylak CJ.

Radiology. 2011 Jan;258(1):243-53. doi: 10.1148/radiol.10091808. Epub 2010 Nov 2.

40.

National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen Biorepository originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654): design, intent, and availability of specimens for validation of lung cancer biomarkers.

Patz EF Jr, Caporaso NE, Dubinett SM, Massion PP, Hirsch FR, Minna JD, Gatsonis C, Duan F, Adams A, Apgar C, Medina RM, Aberle DR.

J Thorac Oncol. 2010 Oct;5(10):1502-6. doi: 10.1097/JTO.0b013e3181f1c634. No abstract available.

41.

25-on-25: twenty-five perspectives on twenty-five years of cardiopulmonary imaging. Part III.

Boiselle PM, Aberle DR, Bankier AA, de Roos A, Gefter WB, Goodman L, Grenier P, Hansell DM, Herold CJ, Im JG, Johkoh T, Kauczor HU, Kazerooni E, Kono M, Levin DC, MacMahon H, McLoud TC, Miller SW, Müller NL, Naidich DP, Prince MR, Rémy-Jardin MR, Schoepf UJ, Stillman AE, Webb WR, White CS.

J Thorac Imaging. 2010 Aug;25(3):W61-6. doi: 10.1097/RTI.0b013e3181eabae6. No abstract available.

PMID:
20711031
42.

25-on-25: twenty-five perspectives on twenty-five years of cardiopulmonary imaging.

Boiselle PM, Aberle DR, Bankier AA, de Roos A, Gefter WB, Goodman L, Grenier P, Hansell DM, Herold CJ, Im JG, Johkoh T, Kauczor HU, Kazerooni E, Kono M, Levin DC, MacMahon H, McLoud TC, Miller SW, Müller NL, Naidich DP, Prince MR, Rémy-Jardin MR, Schoepf UJ, Stillman AE, Webb WR, White CS.

J Thorac Imaging. 2010 Feb;25(1):3-7. doi: 10.1097/RTI.0b013e3181cc9c11. No abstract available.

PMID:
20139777
43.

National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009.

Allegra CJ, Aberle DR, Ganschow P, Hahn SM, Lee CN, Millon-Underwood S, Pike MC, Reed SD, Saftlas AF, Scarvalone SA, Schwartz AM, Slomski C, Yothers G, Zon R.

J Natl Cancer Inst. 2010 Feb 3;102(3):161-9. doi: 10.1093/jnci/djp485. Epub 2010 Jan 13.

PMID:
20071686
44.

NIH state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ (DCIS).

Allegra CJ, Aberle DR, Ganschow P, Hahn SM, Lee CN, Millon-Underwood S, Pike MC, Reed SD, Saftlas AF, Scarvalone SA, Schwartz AM, Slomski C, Yothers G, Zon R.

NIH Consens State Sci Statements. 2009 Sep 24;26(2):1-27.

45.

Assessment of radiologist performance in the detection of lung nodules: dependence on the definition of "truth".

Armato SG 3rd, Roberts RY, Kocherginsky M, Aberle DR, Kazerooni EA, Macmahon H, van Beek EJ, Yankelevitz D, McLennan G, McNitt-Gray MF, Meyer CR, Reeves AP, Caligiuri P, Quint LE, Sundaram B, Croft BY, Clarke LP.

Acad Radiol. 2009 Jan;16(1):28-38. doi: 10.1016/j.acra.2008.05.022.

46.

The partners--airflow obstruction, emphysema, and lung cancer.

Dubinett SM, Aberle DR, Tashkin DP, Mao JT.

Am J Respir Crit Care Med. 2008 Oct 1;178(7):665-6. doi: 10.1164/rccm.200806-902ED. No abstract available.

PMID:
18796652
47.

Lung cancer screening with CT.

Aberle DR, Brown K.

Clin Chest Med. 2008 Mar;29(1):1-14, v. doi: 10.1016/j.ccm.2007.12.001. Review.

48.

The Lung Image Database Consortium (LIDC): a comparison of different size metrics for pulmonary nodule measurements.

Reeves AP, Biancardi AM, Apanasovich TV, Meyer CR, MacMahon H, van Beek EJ, Kazerooni EA, Yankelevitz D, McNitt-Gray MF, McLennan G, Armato SG 3rd, Henschke CI, Aberle DR, Croft BY, Clarke LP.

Acad Radiol. 2007 Dec;14(12):1475-85.

49.

The Lung Image Database Consortium (LIDC) data collection process for nodule detection and annotation.

McNitt-Gray MF, Armato SG 3rd, Meyer CR, Reeves AP, McLennan G, Pais RC, Freymann J, Brown MS, Engelmann RM, Bland PH, Laderach GE, Piker C, Guo J, Towfic Z, Qing DP, Yankelevitz DF, Aberle DR, van Beek EJ, MacMahon H, Kazerooni EA, Croft BY, Clarke LP.

Acad Radiol. 2007 Dec;14(12):1464-74.

50.

The Lung Image Database Consortium (LIDC): ensuring the integrity of expert-defined "truth".

Armato SG 3rd, Roberts RY, McNitt-Gray MF, Meyer CR, Reeves AP, McLennan G, Engelmann RM, Bland PH, Aberle DR, Kazerooni EA, MacMahon H, van Beek EJ, Yankelevitz D, Croft BY, Clarke LP.

Acad Radiol. 2007 Dec;14(12):1455-63.

Supplemental Content

Loading ...
Support Center